Summary
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires.
The report forecast global Biologics and Biosimilars market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation.
The report offers detailed coverage of Biologics and Biosimilars industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Biologics and Biosimilars by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
First, this report covers the present status and the future prospects of the global Biologics and Biosimilars market for 2015-2024.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
At the same time, we classify Biologics and Biosimilars according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Finally, the report provides detailed profile and data information analysis of leading Biologics and Biosimilars company.
Key Content of Chapters as follows (Including and can be customized) :
Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Company information, Sales, Cost, Margin etc.
Part 3:
Global Market by company, Type, Application & Geography
Part 4:
Asia-Pacific Market by Type, Application & Geography
Part 5:
Europe Market by Type, Application & Geography
Part 6:
North America Market by Type, Application & Geography
Part 7:
South America Market by Type, Application & Geography
Part 8:
Middle East & Africa Market by Type, Application & Geography
Part 9:
Market Features
Part 10:
Investment Opportunity
Part 11:
Conclusion
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
Key Companies
NatureWorks
Braskem
BASF
Arkema
DuPont
Novamont
Corbion
Metabolix
PSM
PolyOne
Biome Bioplastics
Biomer
FKuR
Trellis Bioplastics
Kingfa
Cardia Bioplastics
Grabio
MHG
Myriant
Mitsubishi
Zhejiang Hisun Biomaterials
Market by Type
Bio-PET
PHA
Bio-PE
Starch Blends
PLA
Others
Market by Application
Packing Industry
Automotive Industry
Bottles manufacturing
Others
Table of Contents
Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.2.1 Current Situation
1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Market Share by Type in 2019
1.4 By Application
Table Application of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Market Share by Application in 2019
1.5 By Region
Figure Global Biologics and Biosimilars Market Share by Region in 2019
Figure Asia Biologics and Biosimilars Market Share by Region in 2019
Part 2 Key Companies
2.1 NatureWorks
2.1.1 Company Profile
Table NatureWorks Overview List
2.1.2 Products & Services Overview
2.1.3 Sales Data List
Table Biologics and Biosimilars Business Operation of NatureWorks (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
2.2 Braskem
2.3 BASF
2.4 Arkema
2.5 DuPont
2.6 Novamont
2.7 Corbion
2.8 Metabolix
2.9 PSM
2.10 PolyOne
2.11 Biome Bioplastics
2.12 Biomer
2.13 FKuR
2.14 Trellis Bioplastics
2.15 Kingfa
2.16 Cardia Bioplastics
2.17 Grabio
2.18 MHG
2.19 Myriant
2.20 Mitsubishi
2.21 Zhejiang Hisun Biomaterials
Part 3 Global Market Status and Future Forecast
3.1 Global Market by Region
Table Global Biologics and Biosimilars Market by Region, 2015-2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Region in 2019 (Million USD)
3.2 Global Market by Company
Table Global Biologics and Biosimilars Market by Company, 2015-2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Company in 2019 (Million USD)
3.3 Global Market by Type
Table Global Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
3.4 Global Market by Application
Table Global Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
3.5 Global Market by Forecast
Figure Global Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Part 4 Asia-Pacific Market Status and Future Forecast
4.1 Asia-Pacific Market by Type
Table Asia-Pacific Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
4.3 Asia-Pacific Market by Geography
4.3.1 China Market Status and Future Forecast
Figure China Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure China Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
4.3.3 India Market Status and Future Forecast
Figure India Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure India Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
4.3.4 Japan Market Status and Future Forecast
Figure Japan Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Japan Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
4.3.5 Korea Market Status and Future Forecast
Figure Korea Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Korea Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Oceania Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Type
Table Europe Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
5.2 Europe Market by Application
Table Europe Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
5.3 Europe Market by Geography
5.3.1 Germany Market Status and Future Forecast
Figure Germany Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Germany Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.2 UK Market Status and Future Forecast
Figure UK Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure UK Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.3 France Market Status and Future Forecast
Figure France Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure France Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.4 Italy Market Status and Future Forecast
Figure Italy Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Italy Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.5 Russia Market Status and Future Forecast
Figure Russia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Russia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.6 Spain Market Status and Future Forecast
Figure Spain Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Spain Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Turkey Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
5.4 Europe Market by Forecast
Figure Europe Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Part 6 North America Market Status and Future Forecast
6.1 North America Market by Type
Table North America Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
6.2 North America Market by Application
Table North America Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
6.3 North America Market by Geography
6.3.1 United States Market Status and Future Forecast
Figure United States Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure United States Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
6.3.2 Canada Market Status and Future Forecast
Figure Canada Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Canada Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Mexico Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
6.4 North America Market by Forecast
Figure North America Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Part 7 South America Market Status and Future Forecast
7.1 South America Market by Type
Table South America Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
7.2 South America Market by Application
Table South America Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
7.3 South America Market by Geography
7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Brazil Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Argentina Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Columbia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
7.3.4 Chile Market Status and Future Forecast
Figure Chile Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Chile Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
7.3.5 Peru Market Status and Future Forecast
Figure Peru Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Peru Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
7.4 South America Market by Forecast
Figure South America Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Part 8 Middle East & Africa Market Status and Future Forecast
8.1 Middle East & Africa Market by Type
Table Middle East & Africa Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
8.3 Middle East & Africa Market by Geography
8.3.1 GCC Market Status and Future Forecast
Figure GCC Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure GCC Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
8.3.2 North Africa Market Status and Future Forecast
Figure North Africa Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure North Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
8.3.3 South Africa Market Status and Future Forecast
Figure South Africa Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure South Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
8.4 Middle East & Africa Market by Forecast
Figure Middle East & Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Part 9 Market Features
9.1 Product Features
9.2 Price Features
9.3 Channel Features
9.4 Purchasing Features
Part 10 Investment Opportunity
10.1 Regional Investment Opportunity
10.2 Industry Investment Opportunity
PART 11 Coronavirus Impact
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
Part 12 Conclusion
List of Table
Table Type of Biologics and Biosimilars
Table Application of Biologics and Biosimilars
Table NatureWorks Overview List
Table Biologics and Biosimilars Business Operation of NatureWorks (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Life & Medical Business Operation of Braskem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Business Operation of BASF (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Business Operation of Arkema (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table xxx Business Operation of DuPont (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table xx% Business Operation of Novamont (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 19 Business Operation of Corbion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 4 Business Operation of Metabolix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 0 Business Operation of PSM (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 5 Business Operation of PolyOne (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 2230 Business Operation of Biome Bioplastics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 2680 Business Operation of Biomer (Sales Revenue, Cost, Gross Margin)
Table 3480 Business Operation of FKuR (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 112 Business Operation of Trellis Bioplastics (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Kingfa (Sales Revenue, Cost, Gross Margin)
Table A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires. Business Operation of Cardia Bioplastics (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Grabio (Sales Revenue, Cost, Gross Margin)
Table Business Operation of MHG (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Myriant (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Mitsubishi (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Zhejiang Hisun Biomaterials (Sales Revenue, Cost, Gross Margin)
Table Global Biologics and Biosimilars Market by Region, 2015-2019 (Million USD)
Table Global Biologics and Biosimilars Market by Company, 2015-2019 (Million USD)
Table Global Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Global Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Asia-Pacific Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Asia-Pacific Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Europe Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Europe Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table North America Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table North America Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table South America Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table South America Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Middle East & Africa Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Middle East & Africa Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
List of Figure
Figure Global Biologics and Biosimilars Market Share by Type in 2019
Figure Global Biologics and Biosimilars Market Share by Application in 2019
Figure Global Biologics and Biosimilars Market Share by Region in 2019
Figure Asia Biologics and Biosimilars Market Share by Region in 2019
Figure Global Biologics and Biosimilars Market Share by Region in 2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Company in 2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Global Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure China Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure China Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure India Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure India Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Japan Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Japan Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Korea Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Korea Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Oceania Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Oceania Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Germany Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Germany Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure UK Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure UK Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure France Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure France Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Italy Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Italy Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Russia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Russia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Spain Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Spain Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Turkey Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Turkey Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Europe Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure United States Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure United States Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Canada Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Canada Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Mexico Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Mexico Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure North America Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Brazil Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Brazil Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Argentina Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Argentina Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Columbia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Columbia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Chile Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Chile Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Peru Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure Peru Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure South America Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure GCC Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure GCC Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure North Africa Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure North Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure South Africa Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)
Figure South Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
The Biologics Outsourcing Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Sterile Biologics Filling Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...
Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...
North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology s...
Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technologic...
Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discove...
Europe biopharmaceuticals market was valued at $116.5 billion in 2023 and will grow by 8.6% annually over 2023-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical t...
North America biopharmaceuticals market is projected to grow by 8.4% annually in the forecast period and reach $407.2 billion by 2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, ...
Global biopharmaceuticals market will reach $1,001.1 billion by 2033, growing by 8.8% annually over 2023-2033. The growth is driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing cl...